Not Signed In - Heart failure patients perceive improvement in symptoms on Atacand® treatment
Sat, 04 Jun 2005 05:00 AM EST
... A new analysis of the CHARM (Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity) study data published today in the European Journal of Heart Failure1 shows that patients treated with Atacand® (candesartan cilexetil), a selective angiotensin receptor blocker (ARB), perceived greater improvement in their heart failure symptoms compared to those on placebo... click link for more info. ...
Related Topics
- Congestive Heart Failure
- Kidney Failure
- Heart Disease
- Coronary Heart Disease
- Heart Murmur
- Angina
- Heart Diseases
- Congenital Heart Disease
- Heart Attack
- Stroke
- Heart Defects
- BNP
- Right-sided heart failure
- Heart and Circulation
- Heart failure or abnormal rhythm
- Congestive heart failure (rare)
- Left-sided heart failure
- Coronary Disease
- Heart Bypass Surgery
- The signs and symptoms related to the central nervous system may be irreversible if treatment is not begun within 6 months of when these symptoms begin.
email this page
print this page
bookmark this page
feedback on this page
